NRC Health SEC filings NRC
NRC Health has 1,001 filings in SEC EDGAR's recent list, going back to Dec 28, 2007. Its latest annual report, Form ARS, was filed on May 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Sep 19, 2022 | — |
| CORRESP | Letter to the SEC | Sep 14, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 31, 2022 | — |
| EFFECT | Filing | Aug 12, 2019 | — |
| CORRESP | Letter to the SEC | Aug 5, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 10, 2019 | — |
| 15-12B | Deregistration | Apr 17, 2018 | — |
| 8-A12B/A | Form 8-a12b/a | Apr 17, 2018 | — |
| 8-A12B/A | Form 8-a12b/a | Apr 17, 2018 | — |
| 25-NSE | Delisting notice | Apr 17, 2018 | — |
| PRER14A | Form prer14a | Feb 23, 2018 | — |
| CORRESP | Letter to the SEC | Feb 23, 2018 | — |
| UPLOAD | Letter from the SEC | Feb 16, 2018 | — |
| PRER14A | Form prer14a | Jan 26, 2018 | — |
| 425 | Form 425 | Dec 13, 2017 | — |
| PRER14A | Form prer14a | Oct 30, 2017 | — |
| CORRESP | Letter to the SEC | Oct 30, 2017 | — |
| UPLOAD | Letter from the SEC | Oct 25, 2017 | — |
| PRER14A | Form prer14a | Oct 20, 2017 | — |
| CORRESP | Letter to the SEC | Oct 20, 2017 | — |
| UPLOAD | Letter from the SEC | Oct 16, 2017 | — |
| UPLOAD | Letter from the SEC | Aug 25, 2017 | — |
| CORRESP | Letter to the SEC | Aug 3, 2017 | — |
| UPLOAD | Letter from the SEC | Jul 25, 2017 | — |
| EFFECT | Filing | Jul 14, 2016 | — |
| CORRESP | Letter to the SEC | Jul 11, 2016 | — |
| UPLOAD | Letter from the SEC | May 12, 2016 | — |
| UPLOAD | Letter from the SEC | Jul 18, 2013 | — |
| CORRESP | Letter to the SEC | Jul 11, 2013 | — |
| UPLOAD | Letter from the SEC | Jun 28, 2013 | — |
| EFFECT | Filing | Jun 20, 2013 | — |
| CORRESP | Letter to the SEC | Jun 17, 2013 | — |
| CORRESP | Letter to the SEC | Jun 6, 2013 | — |
| CERTNAS | Auto-generated paper document | May 17, 2013 | — |
| 8-A12B/A | Form 8-a/a amendment no. 1 | May 16, 2013 | — |
| 8-A12B | Form 8-a | May 16, 2013 | — |
| UPLOAD | Letter from the SEC | Apr 3, 2013 | — |
| EFFECT | Filing | Oct 9, 2012 | — |
| UPLOAD | Letter from the SEC | Sep 30, 2010 | — |
| CORRESP | Letter to the SEC | Sep 27, 2010 | — |
| UPLOAD | Letter from the SEC | Sep 14, 2010 | — |
| EFFECT | Filing | Jun 25, 2009 | — |
| CORRESP | Letter to the SEC | Jun 22, 2009 | — |
| CORRESP | Letter to the SEC | Jun 12, 2009 | — |
| UPLOAD | Letter from the SEC | Jun 2, 2009 | — |
Showing 45 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- NRC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Lincoln, NE
- SEC filer status
- Accelerated filer
- SEC CIK
- 70487
- Former names
- NATIONAL RESEARCH CORP (until Mar 27, 2026)
Other Services-Commercial Physical & Biological Research companies
- Iqvia Holdings Inc. IQV
- Incyte Corp INCY
- Medpace Holdings, Inc. MEDP
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- Absci Corp ABSI
- OmniAb, Inc. OABI
- Maxcyte, Inc. MXCT
All 17 Services-Commercial Physical & Biological Research companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.